PHP
ASMB icon

Parkman Healthcare Partners’s Assembly Biosciences ASMB Stock Holding History

Parkman Healthcare Partners’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.8M Buy
721,181
+309,954
+75% +$8.44M 2.03% 18
2026
Q1 		$11.4M Buy
411,227
+161,870
+65% +$4.62M 1.18% 27
2025
Q4 		$8.48M Sell
249,357
-1,624
-0.6% -$52.3K 0.81% 42
2025
Q3 		$6.43M Buy
+250,981
New +$5.51M 0.67% 56

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $606M AUM

Parkman Healthcare Partners's ASMB Position: Q2 2026 in Review

Parkman Healthcare Partners increased its Assembly Biosciences (ASMB) stake by 75% in Q2 2026, buying an estimated $8.44M and bringing the position to 721,181 shares worth $19.8M. The position accounts for 2.03% of the portfolio, ranked #18.

Parkman Healthcare Partners first reported a position in ASMB in Q3 2025 and has held it in 4 quarters since. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • Parkman Healthcare Partners held 721,181 shares of Assembly Biosciences worth $19.8M as of Q2 2026.
  • Parkman Healthcare Partners bought 309,954 Assembly Biosciences shares in Q2 2026, an estimated $8.44M.
  • Assembly Biosciences made up 2.03% of Parkman Healthcare Partners's portfolio in Q2 2026, its #18 holding.
  • Parkman Healthcare Partners first reported a position in Assembly Biosciences in Q3 2025 and has held it in 4 quarters since.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on Parkman Healthcare Partners's 13F filing for Q2 2026, filed 14 Aug 2026.